Filing Details
- Accession Number:
- 0000950170-25-073824
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-16 19:07:25
- Reporting Period:
- 2025-05-16
- Filing Date:
- 2025-05-16
- Accepted Time:
- 2025-05-16 19:07:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1858848 | Tenaya Therapeutics Inc. | TNYA | Biological Products, (No Disgnostic Substances) (2836) | 813789973 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1868494 | Whittemore Tingley | C/O Tenaya Therapeutics, Inc. 171 Oyster Point Blvd., 5Th Floor South San Francisco CA 94080 | Chief Medical Officer | No | No | No | No |
Transaction Summary
Sold: | 2,937 shares | Avg. Price: $0.44 | Total Value: $1,300.21 |
Number of Shares After Transactions: | 171,856 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2025-05-16 | 2,937 | $0.44 | 171,856 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on January 24, 2025.
- Includes 107,507 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.